Figure 3.

The effects of various peptides on the conjunctival allergic reaction in guinea pigs. (a) The recombinant peptide R2 reduced clinical allergic signs as much as dexamethasone and Livostin eye drops did. The data are the means of 12 eyes in each group. P values are in Table 2. (b) Eosinophils in the standardized fields of conjunctival epithelium and subepithelial stroma were counted. The recombinant peptide R2 and one peptide of the elafin series (E2) reduced eosinophil infiltration better than dexamethasone and Livostin did. Data are presented as mean of 12 eyes in each group. P values are in the Table 3.